Vesicular Stomatitis New Jersey Virus

Overview and Taxonomy of Vesicular Stomatitis New Jersey Virus

Taxonomic Classification and Position within the Rhabdoviridae Family

Vesicular stomatitis New Jersey virus (VSNJV) is classified as a member of the family Rhabdoviridae, genus Vesiculovirus, a taxonomy that places it among a broader group of enveloped, negative-sense single-stranded RNA viruses with a distinctive bullet-shaped morphology [4, 15]. The species is formally designated Vesiculovirus newjersey, reflecting its serotypic distinction from the Indiana serotype (VSIV, Vesiculovirus indiana) [3, 5]. This taxonomic separation is of profound importance, as VSNJV and VSIV, despite causing clinically indistinguishable disease, exhibit significant differences in their geographic distribution, epidemiological patterns, and molecular pathogenesis. The genus Vesiculovirus encompasses several other notable members, including Chandipura virus, Isfahan virus, and Piry virus, but VSNJV remains the most economically consequential vesiculovirus affecting livestock in the Western Hemisphere [16, 17].

The virion architecture of VSNJV is characteristic of the Rhabdoviridae: a helical nucleocapsid enclosed within a lipid envelope studded with trimeric spikes of the glycoprotein (G). The negative-sense RNA genome, approximately 11 kilobases in length, encodes five structural proteins in a conserved order: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and the large RNA-dependent RNA polymerase (L) [8, 13]. Each of these proteins plays a critical role in the viral life cycle. The N protein encapsidates the genomic RNA, forming the ribonucleoprotein complex essential for transcription and replication. The P protein serves as a cofactor for the L protein, facilitating polymerase processivity. The M protein orchestrates viral assembly and budding, while also functioning as a potent suppressor of host innate immunity [1, 9]. The G protein mediates receptor binding and membrane fusion, primarily through interaction with the low-density lipoprotein receptor (LDLR), a ubiquitous cellular receptor that contributes to the virus's remarkably broad host tropism [14].

Serotypic and Genotypic Diversity: The New Jersey Serotype in Context

The serotypic classification of vesicular stomatitis viruses has historically been based on neutralization assays using polyclonal antisera, which clearly differentiate VSNJV from VSIV. However, within the New Jersey serotype itself, substantial genetic heterogeneity exists, and this diversity has been systematically characterized through phylogenetic analyses of the N, P, and G genes [11, 13]. Field isolates of VSNJV from endemic regions of southern Mexico, Central America, and northern South America cluster into distinct phylogenetic lineages that often correlate more strongly with ecological niche than with temporal or geographic distance alone [11, 17]. This observation challenges simplistic models of viral spread and underscores the complex interplay between viral evolution, vector ecology, and host population dynamics.

The hypervariable region of the phosphoprotein gene has proven particularly useful for molecular epidemiological studies. Rivera et al. (2024) sequenced this region in 51 VSNJV isolates collected over eight years across diverse ecological zones in Venezuela, revealing that viruses from markedly different environments, ranging from high-altitude Andean foothills to lowland tropical plains, did not exhibit significant genetic divergence [11]. This finding contrasts with earlier work in Central America, where environmental variables such as mean annual rainfall, temperature, and elevation were associated with distinct phylogenetic clustering [11, 17]. The discrepancy may reflect differences in vector community composition, host density, or the intensity of viral circulation between regions.

Complete genome sequences of VSNJV field strains have provided unprecedented resolution of the genetic relationships among isolates. Velázquez-Salinas et al. (2018) reported the full-length genomes of two epidemiologically critical strains: NJ0612NME6, a highly virulent epidemic strain responsible for the 2012 U.S. outbreak, and a closely related endemic strain from southern Mexico [13]. These sequences, differing by only a handful of nucleotide substitutions, serve as an ideal model system for identifying the molecular determinants of virulence and emergence. The near-identity of these strains suggests that epidemic VSNJV strains do not arise through major genetic reassortment but rather through subtle mutations that enhance replication efficiency in livestock hosts, a hypothesis strongly supported by subsequent functional studies of the M protein [1, 9].

Genomic Architecture and Functional Anatomy

The VSNJV genome, like that of all vesiculoviruses, is organized as a linear, non-segmented RNA molecule of negative polarity. Transcription proceeds in a sequential, stop-start manner from the 3' end, yielding a gradient of mRNA abundance that decreases with distance from the promoter. The leader RNA, a short non-coding region at the 3' terminus, serves as the promoter for both transcription and replication. The intergenic regions, though short, contain conserved sequence motifs that govern polymerase stuttering and mRNA capping.

The matrix protein gene has received intense scrutiny due to its multifaceted roles in pathogenesis. The M protein of VSNJV, a 229-amino acid polypeptide, not only drives viral assembly by coordinating the condensation of nucleocapsids at the plasma membrane but also actively subverts the host antiviral response. A single amino acid substitution at position 51 (M51R) within the M protein abrogates its ability to suppress interferon-β gene expression, rendering the virus incapable of replicating efficiently in porcine macrophages [1]. This mutation, when engineered into the epidemic strain NJ0612NME6, produced a partially attenuated phenotype in pigs: infected animals developed fewer and smaller secondary vesicular lesions, exhibited reduced fever and viral shedding, and lacked detectable RNAemia [1]. Importantly, the M51R mutant retained the capacity for direct contact transmission, indicating that virulence and transmissibility are at least partially separable traits. These findings have profound implications for vaccine development, as M gene mutations, specifically the G22E, M48R, M51R, and L110F substitutions in the New Jersey serotype, have been incorporated into recombinant VSV vectors to generate safe and immunogenic vaccine platforms [14].

The glycoprotein G is equally critical, not only for receptor binding and entry but also as the primary target of neutralizing antibodies. The G protein forms homotrimeric spikes on the virion surface and undergoes a pH-dependent conformational change that drives membrane fusion within acidified endosomes. Its ectodomain is heavily glycosylated, a feature that may contribute to immune evasion by masking conserved epitopes. The honeybee melittin signal peptide has been used to enhance G protein expression and incorporation into recombinant vesicular stomatitis virus (rVSV) particles, boosting the immunogenicity of vectored vaccines [14]. Moreover, the transmembrane domain and cytoplasmic tail of VSV G have been exploited to anchor foreign glycoproteins onto pseudotyped virions, enabling the development of chimeric vaccine vectors targeting a wide range of viral pathogens [14, 19].

Phylogenetic Relationships and Evolutionary Dynamics

Phylogenetic analyses of VSNJV have consistently revealed that isolates from the endemic zone in southern Mexico and Central America form a genetically diverse reservoir from which epidemic strains sporadically emerge to cause outbreaks in the United States. The 2012 and 2023 U.S. epidemics, for instance, were caused by VSNJV strains that are nearly identical to contemporary isolates from Chiapas, Mexico, suggesting that the virus is repeatedly introduced northward, likely through infected insect vectors or livestock movements [13, 16]. The close relationship between epidemic and endemic strains implies that VSNJV does not require extensive adaptation to invade new geographic regions; rather, the key limiting factors may be ecological, particularly the presence of competent vector populations and susceptible hosts.

The role of insect vectors in shaping VSNJV evolution cannot be overstated. The virus has been isolated from a diverse array of hematophagous arthropods, including biting midges (Culicoides spp.), black flies (Simulium spp.), sand flies (Lutzomyia spp.), and mosquitoes [16, 17]. During the 2023 southern California outbreak, VSNJV RNA was detected in nine species across two genera, several of which had never previously been implicated in VSV transmission: Culicoides bergi, C. freeborni, C. occidentalis, Simulium argus, S. hippovorum, and S. tescorum [16]. The vector competency of these newly identified species remains to be experimentally confirmed, but their involvement suggests that VSNJV can exploit a broader range of insect hosts than previously appreciated. This ecological plasticity may facilitate the persistence of the virus in enzootic cycles that operate independently of livestock, as evidenced by the detection of VSNJV in insects during the dry season in Chiapas, when no clinical cases in cattle were reported [17].

The evolutionary rate of VSNJV, estimated from phosphoprotein gene sequences, is moderate for an RNA virus but sufficient to generate measurable genetic drift over decadal timescales. Historical isolates, such as the 1965 strain from El Salvador, provide a temporal anchor for molecular clock analyses and reveal that the virus has circulated in Central America with remarkable genetic stability [5]. This stability stands in contrast to the rapid evolution observed in some other RNA viruses and may reflect constraints imposed by the need to replicate in both mammalian and insect hosts, each imposing distinct selective pressures.

Host Range and Zoonotic Potential

The natural host range of VSNJV encompasses a wide array of mammalian species, with domestic livestock, cattle, horses, and swine, bearing the brunt of clinical disease [2, 6, 15]. However, the virus is far from restricted to these hosts. The 2023 outbreak in a California zoological park provided the first documented evidence of VSNJV infection in rhinoceros, affecting both southern white rhinoceros (Ceratotherium simum simum) and greater one-horned rhinoceros (Rhinoceros unicornis) [18]. Clinical presentation in these animals ranged from mild mucocutaneous lesions to severe systemic illness with lameness, anorexia, and hypersalivation, underscoring the potential for VSV to cause significant morbidity in non-domestic species. Viral RNA was localized within histological lesions by in situ hybridization, confirming active viral replication in tissues [18].

Feral swine have also been identified as potential amplifying hosts for VSNJV, although serosurveillance efforts in the western United States from 2013 to 2021 found a very low prevalence of neutralizing antibodies, only a single animal from Texas tested positive for VSIV, and none for VSNJV [20]. This finding argues against the existence of an endemic reservoir in feral swine populations in the region and suggests that outbreaks are driven by northward viral incursions rather than local enzootic maintenance.

Zoonotic transmission of VSNJV to humans is well-documented, though clinical disease is typically mild and self-limiting. Occupational exposure, particularly among agricultural workers, veterinarians, and laboratory personnel, represents the primary risk factor. A cross-sectional serosurvey conducted in two dairy cantons of Costa Rica revealed VSNJV seroprevalences of 40.8% in Poás and 26.2% in Tilarán, with agricultural workers showing a significantly elevated risk (RR = 2.28) [12]. These figures align with historical data from other Central American countries and underscore the importance of VSV as a zoonotic pathogen. Human infection typically manifests as an acute febrile illness with headache, myalgia, and, in some cases, vesicular lesions on the hands or mouth. The virus is classified as a Biosafety Level 2 (BSL-2) agent by the Centers for Disease Control and Prevention (CDC) and is reportable to the World Organisation for Animal Health (WOAH) due to its clinical mimicry of foot-and-mouth disease (FMD) [2]. The differential diagnosis of VSV from FMD virus is a critical veterinary public health priority, and rapid molecular assays such as reverse transcription loop-mediated isothermal amplification (RT-LAMP) have been developed specifically to distinguish these pathogens in field settings [2].

Ecological and Epidemiological Context

The epidemiology of VSNJV is inextricably linked to its insect vector ecology. Experimental transmission studies have demonstrated that both Culicoides sonorensis and Simulium vittatum can transmit the virus to livestock, leading to seroconversion and, in some cases, clinical disease [4, 6, 7, 15]. The site of insect feeding is a critical determinant of clinical outcome: black flies feeding on the mouth, nostrils, or coronary band, sites where vesicular lesions typically occur, induced robust local replication, vesicle formation, and high neutralizing antibody titers, whereas feeding on the flank or neck resulted in poor replication and no visible lesions [6]. This tissue tropism suggests that successful transmission requires virus deposition in sites permissive for initial replication, a factor that may explain the high proportion of subclinical infections observed during epidemics [4, 10].

Mechanical transmission, whereby virus is carried on the mouthparts of insects that have fed on vesicular lesions and then feed on a naïve host, has also been experimentally confirmed. Smith et al. (2009) demonstrated that black flies mechanically transmitted VSNJV from infected to naïve swine after interrupted feeding, resulting in clinical disease [7]. This mode of transmission may be particularly important during outbreaks when high viral loads are present in lesion exudates. The combination of biological replication within the vector and mechanical transfer by contaminated mouthparts likely contributes to the explosive nature of VSNJV epizootics.

The endemic focus of VSNJV in southern Mexico and Central America is characterized by year-round transmission, with peak incidence during and immediately after the rainy season. In Chiapas, Mexico, a two-year longitudinal study detected VSNJV RNA in all four potential vector taxa, black flies, sand flies, biting midges, and mosquitoes, throughout the year, even during the dry season when no livestock cases were reported [17]. This finding implies that the virus is maintained in a cryptic enzootic cycle involving wild mammals or other reservoir hosts, independent of domestic livestock. The identification of these maintenance hosts and the mechanisms by which VSNJV persists through seasonal bottlenecks remains one of the most urgent unanswered questions in VSV ecology.

Economic Impact and Global Significance

Vesicular stomatitis causes substantial economic losses through reduced productivity in affected livestock, trade restrictions imposed to prevent the spread of a vesicular-disease-causing agent, and the costs of diagnostic testing and surveillance. Because the clinical signs of VS, vesicular lesions on the mouth, tongue, coronary bands, and teats, are indistinguishable from those of FMD, any suspicion of VS triggers an immediate regulatory response, including quarantine and laboratory testing [2]. In endemic regions, this diagnostic burden consumes significant veterinary resources and complicates efforts to achieve FMD-free status. The World Organisation for Animal Health (WOAH) lists VS as a notifiable disease, and international trade in livestock and livestock products from affected regions may be restricted.

The 2023 outbreak in California, Nevada, and Texas, which affected horses, cattle, and rhinoceros, provided a stark reminder of the virus's capacity to disrupt animal health and agriculture in the United States [16, 18]. Despite decades of research, the factors that precipitate northward emergence from the endemic zone remain poorly understood, hampering efforts to predict and prevent future epidemics. The development of reverse genetic systems for VSNJV, including the construction of full-length infectious cDNA clones [8], has opened new avenues for dissecting the molecular determinants of virulence and transmission, but translating these insights into practical control measures will require sustained investment in both laboratory and field research.

In summary, VSNJV is a genetically and ecologically complex virus that occupies a unique niche among the vesiculoviruses. Its dual-host life cycle, involving replication in both mammalian and insect cells, imposes distinct evolutionary constraints that shape its genome structure, protein function, and transmission dynamics. The virus's ability to cause severe disease in a wide range of hosts, including non-domestic species and humans, combined with its potential for rapid spread via arthropod vectors, makes it a persistent threat to animal health and agricultural economies across the Americas. The sections that follow will delve into the molecular biology, pathogenesis, and immune evasion strategies of VSNJV, building upon the taxonomic and ecological foundation established here.

Molecular Pathogenesis: Role of Matrix Protein M51 Residue in Replication and Innate Immune Evasion

The matrix protein (M protein) of vesicular stomatitis New Jersey virus (VSNJV) represents a central determinant of viral pathogenesis, orchestrating both fundamental replicative processes and sophisticated countermeasures against the host innate immune system. Among the myriad residues comprising this multifunctional protein, the methionine at position 51 (M51) has emerged as a critical linchpin whose integrity is essential for full virulence, efficient replication in myeloid cells, and suppression of interferon (IFN)-mediated antiviral responses. The elucidation of M51 function has been propelled by the development of recombinant VSNJV clones, particularly the highly virulent epidemic strain NJ0612NME6, which has enabled precise structure-function analyses through site-directed mutagenesis [1, 8]. This residue’s role is not merely ancillary but rather constitutes a non-redundant requirement for the virus to establish productive infection in natural hosts, particularly swine and cattle, which are primary targets during epizootics in the Americas [1, 13, 21].

The M51R Mutation and Its Impact on Viral Replication in Myeloid Cells

The substitution of arginine for methionine at position 51 (M51R) in the VSNJV matrix protein produces a profound and cell-type-specific replication defect that illuminates the virus’s reliance on myeloid cell permissiveness for systemic dissemination. In primary fetal porcine kidney cells, the M51R mutant replicates with kinetics and to titers comparable to the parental wild-type virus, indicating that the M51 residue is dispensable for replication in non-immune epithelial or fibroblast lineages [1]. However, a stark contrast emerges in porcine primary macrophage cultures, where the M51R mutant exhibits severely impaired growth, with viral titers reduced by several orders of magnitude relative to the parental strain [1]. This macrophage-specific restriction is mechanistically informative: it suggests that the wild-type M51 residue functions to counteract an antiviral state that is uniquely or most potently activated in cells of the monocyte-macrophage lineage. Macrophages serve as sentinel cells of the innate immune system, acting as both first responders to viral infection and critical mediators of adaptive immunity. The World Organisation for Animal Health (WOAH) recognizes that vesicular stomatitis virus pathogenesis in livestock is intimately linked to the virus’s ability to subvert these early immune defenses, and the M51-dependent replication in macrophages represents a key virulence determinant [1, 9].

The biological significance of this replication defect is underscored by the observation that the M51R mutant fails to suppress the transcription of genes associated with the innate immune response in both primary fetal porcine kidney cells and porcine macrophage cultures [1]. Transcriptomic analyses have revealed that wild-type VSNJV infection induces a massive dysregulation of host gene expression, including the upregulation of anorexic, pyrogenic, proinflammatory, and immunosuppressive genes, while simultaneously suppressing the interferon response and preventing the stimulation of interferon-stimulated genes (ISGs) [9]. The M51R mutant, by contrast, is unable to maintain this suppression, leading to the robust expression of antiviral genes that likely contribute to its replication defect. This dichotomy highlights the M51 residue as a critical node in the virus’s immune evasion strategy, where its mutation converts a potent immunosuppressive virus into one that is recognized and controlled by the host’s intrinsic antiviral machinery.

Molecular Mechanisms of Innate Immune Evasion Mediated by M51

The matrix protein of VSNJV employs multiple, overlapping mechanisms to subvert the host interferon response, and the M51 residue is central to several of these strategies. Canonically, the VSV matrix protein has been shown to inhibit host gene expression by blocking nuclear-cytoplasmic transport, specifically by interacting with the nucleoporin Nup98 and Rae1 to prevent the nuclear export of cellular mRNAs while selectively allowing viral mRNA export [1, 9]. The M51 residue is critical for this function; its mutation to arginine abrogates the ability of the M protein to inhibit host transcription and mRNA export, thereby restoring the cell’s capacity to mount an antiviral response. This is consistent with the observation that M51R-infected cells exhibit robust upregulation of IFN-β and ISGs, whereas wild-type virus-infected cells show a profound suppression of these pathways [1, 9].

Beyond the canonical mRNA export block, recent evidence suggests that VSNJV employs additional, M51-dependent mechanisms to fine-tune the interferon response. Transcriptomic profiling of infected porcine macrophages has revealed that wild-type VSNJV infection promotes the expression of several genes known to downregulate IFN-β expression, representing an alternate, parallel mechanism for controlling the IFN response that extends beyond the matrix protein’s direct effects on nuclear transport [9]. This finding indicates that the M51 residue may orchestrate a broader transcriptional reprogramming of the host cell, tipping the balance toward a state that is permissive for viral replication. The M51R mutation disrupts this reprogramming, allowing the cell to activate its full antiviral transcriptional program. The interplay between these mechanisms is likely context-dependent, varying with cell type, multiplicity of infection, and the specific genetic background of the viral strain. For instance, comparative analyses of epidemic versus endemic VSNJV strains have shown that while both induce similar qualitative patterns of gene expression, the endemic strain consistently induces higher expression of all upregulated cytokines and chemokines, suggesting that subtle differences in M protein function, potentially at the M51 residue or in its vicinity, contribute to strain-specific virulence [9].

In Vivo Attenuation and Correlates of Virulence in Natural Hosts

The critical role of the M51 residue in VSNJV pathogenesis is most dramatically demonstrated through experimental infections of swine, which are natural hosts and an important WOAH-listed species for vesicular stomatitis surveillance [1, 22]. Intradermal scarification of the snout with the M51R mutant virus results in a significantly attenuated phenotype compared to the parental wild-type strain. Pigs infected with the M51R mutant exhibit decreased clinical signs, including reduced fever and the development of fewer and smaller secondary vesicular lesions [1]. This attenuation correlates directly with the virus’s inability to replicate efficiently in macrophages, as the systemic dissemination of VSNJV is thought to depend on the infection of monocytes and macrophages that traffic from the initial inoculation site to secondary lymphoid tissues and epithelial surfaces [1, 9]. The reduced viral shedding observed in M51R-infected pigs, coupled with the absence of RNAemia (detectable viral RNA in the blood), further supports the model that macrophage infection is a prerequisite for systemic spread and the establishment of widespread vesicular lesions [1].

Strikingly, despite its attenuation, the M51R mutant retains the ability to infect pigs by direct contact, resulting in primary vesicular lesions at the site of inoculation and transmission to sentinel animals [1]. This indicates that the M51R mutation results in a partially attenuated, rather than fully avirulent, phenotype. The virus can still establish a localized infection at the portal of entry, likely through infection of epithelial cells and keratinocytes, which do not require M51 function for efficient replication [1]. However, the inability to productively infect macrophages limits subsequent dissemination, reducing the severity of clinical disease and the magnitude of viral shedding. This partial attenuation has significant implications for vaccine development. Indeed, the M51R mutation, often in combination with other attenuating mutations such as G22E, M48R, and L111F, has been incorporated into recombinant VSV vectors to create safe and immunogenic vaccine platforms [14]. These M gene mutant vectors, including rVSVNJ-GMM and rVSVNJ-GMML, exhibit dramatically reduced cytopathic effects in vitro and are avirulent in animal models, with doses of up to 5 billion live virus particles causing no significant adverse effects in mice, whereas as few as 1,000 wild-type VSV particles are lethal [14]. The World Health Organization (WHO) and other global health bodies have recognized the potential of such attenuated VSV vectors for pandemic preparedness, given their ability to induce robust humoral and cellular immune responses against heterologous viral glycoproteins [14].

Broader Implications for VSNJV Epidemiology and Pathogenesis

The M51 residue’s role in macrophage tropism and innate immune evasion has profound implications for understanding the natural history and epidemiology of VSNJV in its endemic range, which spans from southern Mexico through Central America and into northern South America [3, 5, 11, 17]. In these regions, VSNJV is maintained in enzootic cycles involving insect vectors, particularly biting midges (Culicoides spp.) and black flies (Simulium spp.), and susceptible livestock hosts [4, 6, 7, 15-17]. The ability of VSNJV to replicate in macrophages and suppress the innate immune response is likely a key adaptation that allows the virus to achieve high titers in the skin and blood of infected animals, facilitating subsequent acquisition by hematophagous vectors. Experimental transmission studies have demonstrated that VSNJV can be transmitted to cattle and swine by the bite of infected Culicoides sonorensis and Simulium vittatum, respectively, resulting in clinical disease [4, 6, 7, 15]. The site of insect feeding is critical; feeding at sites where vesicular lesions typically occur (e.g., mouth, nostrils, coronary band) results in robust local replication and clinical disease, whereas feeding on flank or neck skin leads to poor replication and subclinical infection [6]. This site-dependent pathogenesis may be explained, at least in part, by the differential availability of permissive macrophage populations at these anatomical sites.

The M51 residue may also contribute to the differential virulence observed among VSNJV strains circulating in endemic versus epidemic settings. Phylogenetic analyses have revealed that epidemic strains from the United States are closely related to endemic strains from southern Mexico, yet they exhibit enhanced virulence in livestock [13, 21]. While the complete genetic basis for this difference remains to be fully elucidated, the M protein, and particularly the M51 residue, is a prime candidate. Comparative genomic studies of epidemic and endemic VSNJV strains have identified polymorphisms in the M gene that may affect protein function, and functional assays have shown that epidemic strains are more efficient at suppressing the innate immune response in porcine macrophages [9, 13]. The M51 residue itself is highly conserved among VSNJV isolates, but subtle differences in its local environment or in other domains of the M protein could modulate its activity. Furthermore, the phosphoprotein (P) gene, which encodes the hypervariable region often used for molecular epidemiology, also shows evidence of ecological adaptation, suggesting that multiple viral genes contribute to host range and virulence [11].

The relevance of the M51 residue extends beyond livestock to include wildlife species that may serve as amplifying hosts or sentinels for VSNJV activity. Feral swine (Sus scrofa) have been identified as potential amplifying hosts, and serosurveillance studies have detected antibodies to VSNJV in feral swine populations in the western United States, although at low prevalence [20]. The ability of VSNJV to replicate in swine macrophages, which is dependent on M51 function, is likely a critical determinant of the virus’s ability to establish infection in these animals. Similarly, the recent outbreak of VSNJV in southern white rhinoceros and greater one-horned rhinoceros at a California zoological park highlights the broad host range of this virus and the importance of understanding its molecular pathogenesis across species [18]. The clinical signs observed in rhinoceros, including lethargy, lameness, and vesicular lesions on the coronary bands and oral mucosa, are reminiscent of those seen in livestock, suggesting that similar pathogenic mechanisms, including M51-dependent immune evasion, are at play [18]. The detection of VSNJV in multiple insect vector species during the 2023 outbreak in Southern California further underscores the complex ecology of this virus and the need for continued research into the molecular determinants of its transmission and pathogenesis [16].

In summary, the M51 residue of the VSNJV matrix protein is a master regulator of viral replication in macrophages and a critical effector of innate immune evasion. Its mutation to arginine abrogates the virus’s ability to suppress the interferon response, restricts replication in myeloid cells, and results in significant attenuation in swine, a natural host. These findings establish a direct causal link between the virus’s capacity to counteract the innate immune response in macrophages and its virulence in vivo. The M51 residue thus represents a key target for rational vaccine design and a critical focus for understanding the molecular epidemiology and pathogenesis of this economically important and zoonotic pathogen.

Epidemiology and Transmission Dynamics in Endemic Regions of the Americas

Vesicular stomatitis New Jersey virus (VSNJV) represents a significant and economically burdensome pathogen for livestock industries across the Americas, yet its epidemiology remains remarkably complex and incompletely understood. The virus is classified as a zoonotic agent by the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH), and its clinical similarity to foot-and-mouth disease (FMD) imposes stringent differential diagnostic requirements on veterinary services throughout the Western Hemisphere [2]. The endemic range of VSNJV is broadly defined as extending from southern Mexico through Central America and into the northern tier of South America, with sporadic epizootic incursions into the western United States [2, 3, 11]. Understanding the transmission dynamics within this endemic zone is critical not only for predicting and controlling outbreaks but also for deciphering the mechanisms that permit viral perpetuation in the absence of clinical disease.

Geographic and Seasonal Patterns of Endemicity

The state of Chiapas in southern Mexico is widely recognized as a principal ecological niche for VSNJV endemicity. Longitudinal surveillance conducted across five cattle ranches in Chiapas over a two-year period revealed that vesicular stomatitis (VS) cases occur predominantly during the rainy season (May to October) and the immediate post-rainy season, with 20 of 22 reported cases concentrated in the rainy months [17]. This seasonal clustering aligns with the activity peaks of hematophagous Diptera, which are believed to be the primary biological vectors. Importantly, this same study detected VSNJV RNA in insect pools, including black flies, sandflies, biting midges, and mosquitoes, collected during the dry season, a period when no clinical livestock cases were reported [17]. This finding is pivotal, as it suggests that virus circulation continues in the absence of overt disease, likely maintained through a sylvatic cycle or cryptic transmission among non-livestock hosts. The seroprevalence data from Chiapas further underscore the endemic nature of VSNJV in this region: neutralizing antibodies against VSNJV were detected in 75–100% of adult cattle across all five ranches, in stark contrast to the 0.6% seroprevalence observed for the Indiana serotype (VSIV) [17]. This near-universal exposure in adult animals implies that virtually all cattle in these endemic zones become infected early in life, developing immunity that may modulate the clinical expression of subsequent infections.

The geographic distribution of VSNJV extends well beyond Mexico. In Venezuela, molecular analysis of 51 isolates collected between 2009 and 2017 demonstrated that the virus circulates across a remarkably diverse array of ecological conditions, including high-altitude Andean regions and lowland tropical plains, with variable patterns of precipitation and temperature [11]. This ecological plasticity challenges earlier assumptions that VSNJV transmission is tightly constrained by specific environmental parameters. Indeed, while previous epidemiological studies in Central America identified associations between VSNJV seropositivity and factors such as mean annual rainfall, elevation, and temperature, the Venezuelan data revealed that phylogenetic clustering of viral isolates was not strictly correlated with ecological zone [11]. This suggests that host population dynamics, vector community composition, and perhaps viral strain-specific fitness traits may be more influential determinants of transmission success than abiotic factors alone.

Vector Biology and Transmission Mechanisms

The role of hematophagous insects in VSNJV transmission has been definitively established through a series of rigorous experimental and field studies. Laboratory investigations have demonstrated successful biological transmission of VSNJV to livestock by two principal vector genera: Culicoides biting midges and Simulium black flies [4, 6, 15]. The vector competence of Culicoides sonorensis was first confirmed when intrathoracically inoculated midges transmitted VSNJV to steers during blood feeding, resulting in seroconversion in all exposed animals, although clinical lesions were not observed at the insect feeding site [4]. Strikingly, the animals infected via C. sonorensis bite exhibited a significantly slower antibody response compared to those receiving intralingual inoculation, likely reflecting the lower dose of virus delivered by insect bite [4]. This finding has profound epidemiological implications: widespread subclinical infections during epidemics may be far more common than previously recognized, with seroconversion occurring without the overt vesicular lesions that typically trigger diagnostic investigation.

In contrast, transmission by Simulium vittatum has been shown to produce clinical disease, but the outcome is exquisitely dependent on the anatomical site of insect feeding. When infected black flies fed on the mouth, nostrils, or coronary band, sites where VS lesions naturally occur, cattle developed characteristic vesicles, robust neutralizing antibody titers exceeding 1:256, and sustained viral RNA detection in draining lymph nodes for up to nine days post-infection [6]. However, when flies fed on the flank or neck skin, viral replication was poor, no lesions developed, and antibody responses were weak (titers of 1:8–1:32) [6]. This site-dependent susceptibility explains a critical epidemiological paradox: despite abundant vector populations, not all exposed animals develop clinical disease. The predilection of VSNJV for mucocutaneous junctions and the coronary band is not merely a clinical curiosity but a fundamental determinant of transmission efficiency. Viremia was notably absent in all experimentally infected animals, reinforcing the concept that VSNJV is a locally replicating pathogen that does not disseminate systemically via the bloodstream in cattle [6, 22].

The distinction between biological and mechanical transmission is epidemiologically significant. Biological transmission, wherein the virus replicates within the vector, allows for sustained infectivity over days to weeks and may facilitate long-distance dispersal if infected insects are carried by wind currents. Mechanical transmission, on the other hand, involves the direct transfer of virus on contaminated mouthparts following interrupted feeding. A proof-of-concept study demonstrated that S. vittatum could mechanically transmit VSNJV to naïve swine after interrupted feeding on a vesicular lesion, resulting in clinical disease in the recipient host [7]. This mechanism is particularly relevant during outbreaks when multiple animals are feeding in close proximity and lesions are fresh and teeming with infectious virus. The 2023 multistate outbreak in the United States, which affected horses, cattle, and even rhinoceros, provided field validation of these experimental findings: VSNJV RNA and infectious virus were detected in wild-caught Culicoides and Simulium species, including C. bergi, C. freeborni, C. occidentalis, S. argus, S. hippovorum, and S. tescorum, many of which had not previously been implicated in VSNJV transmission [16]. The vector competency of these newly identified species remains to be determined experimentally, but their detection underscores the breadth of the arthropod community that may support VSNJV amplification and spread.

Livestock Host Dynamics and Viral Shedding

Cattle and swine are the primary domestic livestock hosts for VSNJV, but their roles in transmission and maintenance differ substantially. Experimental challenge studies have revealed marked differences in clinical presentation and viral shedding between these two species, with important consequences for epidemic spread. In cattle, infection with homologous VSNJV strains (those isolated from the same host species) resulted in significantly more severe clinical signs and greater duration and magnitude of viral shedding compared to infection with heterologous strains [21]. This host predilection suggests that viral strains may be adapted to specific livestock species, and that spillover events between species may be less efficient than within-species transmission. For swine, clinical severity and shedding patterns did not differ significantly between homologous and heterologous strains, indicating that pigs may serve as permissive hosts for a broader range of VSNJV variants [21].

The temporal dynamics of viral shedding are critical for understanding transmission risk. In swine experimentally infected via intradermal snout inoculation, infectious virus was isolated from swabs of the nasal planum, nasal cavity, saliva, tonsil, and feces, with the highest titers detected when vesicular lesions were present and before the onset of seroconversion [22]. Once neutralizing antibodies develop, shedding declines rapidly. The minimum infectious dose for swine was remarkably low, as little as 10² TCID₅₀ applied to scarified skin or oral mucosa was sufficient to establish infection, indicating that even brief contact with contaminated fomites or insect mouthparts could initiate new cases [22]. Importantly, virus was not isolated from plasma in any animal, confirming the absence of viremia and reinforcing that VSNJV transmission requires direct inoculation of virus into susceptible epithelium or mucous membranes.

Pigs infected with a partially attenuated VSNJV mutant containing the M51R amino acid substitution in the matrix protein exhibited decreased clinical signs, reduced fever, fewer secondary vesicular lesions, and markedly lower levels of viral shedding [1]. However, the ability of this mutant virus to infect sentinel pigs by direct contact remained intact, demonstrating that even attenuated strains can sustain transmission chains [1]. This finding has implications for vaccine development: the M51R mutation, which impairs the virus's ability to suppress the innate immune response in porcine macrophages, results in a partially attenuated phenotype that retains transmissibility [1, 14]. The development of recombinant VSV-based vaccine vectors incorporating multiple attenuating mutations in the M gene (G21E, M51R, L111F for the Indiana serotype; G22E, M48R, M51R, L110F for the New Jersey serotype) represents a promising approach for creating safe and immunogenic vaccines, though the potential for reversion to virulence or transmission of vaccine strains must be carefully evaluated [14].

Human Seroprevalence and Zoonotic Risk

While VSNJV is primarily considered a veterinary pathogen, its zoonotic potential is well-documented and may be substantially underestimated in endemic regions. The first serosurvey of human exposure to VSNJV in Costa Rica, conducted in dairy farming communities, revealed startlingly high seroprevalence rates. In the canton of Poás, 40.8% of human serum samples contained neutralizing antibodies against VSNJV, while 16.7% were positive for VSIV [12]. Agricultural workers had a relative risk of VSNJV seropositivity of 2.28 compared to non-agricultural workers, and direct cattle contact was significantly associated with VSIV seropositivity (RR = 4.22) [12]. In the canton of Tilarán, VSNJV seroprevalence was 26.2%, and direct cattle contact was the only significant risk factor identified (RR = 6.14) [12]. These data indicate that occupational exposure to livestock is a major driver of human infection, and that a substantial proportion of the rural population in endemic areas may experience VSNJV infection, often likely inapparent or misdiagnosed as non-specific febrile illness.

The public health significance of these findings is amplified by the absence of routine surveillance for VSNJV in human populations. The clinical presentation in humans is typically a self-limited febrile illness, occasionally accompanied by vesicular lesions on the hands or oral mucosa, but the true incidence is unknown because diagnostic testing is rarely pursued. The United States Centers for Disease Control and Prevention (CDC) classifies VSV as a Biosafety Level 2 agent and acknowledges its zoonotic potential, yet human cases are not nationally notifiable in most countries. Integrating VSV surveillance into existing febrile illness monitoring systems in endemic regions, particularly in agricultural communities, would provide critical data on the true burden of human disease and could inform occupational health guidelines. The detection of neutralizing antibodies in feral swine (Sus scrofa) in the western United States is rare, only one of 4,541 samples tested positive for VSIV antibodies, suggesting that feral swine do not constitute a maintenance reservoir for VSNJV in that region [20]. However, the potential for feral swine to act as amplifying hosts during epizootics remains a concern, as their wide-ranging movements and high reproductive rates could facilitate viral spread.

The Endemic-Epizootic Interface and Evolutionary Dynamics

The relationship between endemic circulation in southern Mexico and Central America and the sporadic epizootics that occur in the western United States has been a subject of considerable investigation. Complete genome sequences of VSNJV field strains from Mexico and the United States have revealed close phylogenetic relationships, supporting the hypothesis that U.S. outbreaks are seeded by viral introduction from the endemic zone rather than by local overwintering or maintenance [13]. The near full-length genome sequence of a VSNJV isolate from a naturally infected cow in Chiapas, Mexico, provides a contemporary reference for tracking the evolutionary trajectory of circulating strains [3]. Similarly, a historical isolate collected in El Salvador in 1965 offers a temporal anchor for understanding long-term genetic drift and the emergence of epidemic lineages [5]. The phosphoprotein (P) gene hypervariable region has been particularly useful for molecular epidemiological studies, as it exhibits sufficient genetic diversity to differentiate strains across spatial and temporal scales, yet remains conserved enough to reflect evolutionary relationships [11].

Viral genetic factors clearly influence transmission dynamics. The matrix (M) protein is a major determinant of virulence, primarily through its role in suppressing the host interferon response. Infection of porcine macrophages with VSNJV induces massive expression of proinflammatory, anorexic, pyrogenic, and immunosuppressive genes, while simultaneously suppressing interferon-stimulated gene (ISG) expression [9]. This transcriptional reprogramming creates a favorable environment for viral replication and may facilitate systemic dissemination. Interestingly, comparison of a highly virulent epidemic strain with a less virulent endemic strain revealed no significant differences in the repertoire of genes induced, but the endemic strain consistently triggered higher expression levels of all upregulated cytokines and chemokines [9]. This suggests that the magnitude, rather than the quality, of the innate immune response may distinguish epidemic from endemic strains. The ability of the M51R mutant to replicate efficiently in porcine macrophages is abrogated, correlating with its attenuated phenotype in pigs and underscoring the centrality of macrophage infection to VSNJV pathogenesis [1].

Implications for Surveillance and Control

The complexity of VSNJV transmission dynamics in endemic regions demands a multi-faceted surveillance strategy that integrates livestock case reporting, vector monitoring, and serosurveillance. The detection of VSNJV RNA in insect vectors during periods when no clinical cases are reported in livestock strongly suggests that virus is maintained in an alternative reservoir, perhaps in wild rodents, bats, or other sylvatic hosts [17]. Identifying this reservoir is a research priority, as it would enable targeted interventions to interrupt the spillover cycle. The development of rapid molecular diagnostics, such as reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays that can differentiate VSNJV from FMD virus in field settings without the need for RNA extraction, represents a transformative advance for surveillance in resource-limited settings [2]. Such assays can be deployed at the point of care, enabling rapid confirmation of VS cases and reducing the economic impact of unnecessary movement restrictions.

The emergence of VSNJV in novel hosts, such as the southern white rhinoceros (Ceratotherium simum simum) and greater one-horned rhinoceros (Rhinoceros unicornis) during the 2023 California outbreak, highlights the expanding host range of this virus and the potential for infection in endangered species [18]. The clinical presentation in rhinoceros included severe systemic illness, lameness, and difficulty with prehension, yet all animals survived with supportive care [18]. This event underscores the importance of including VSV in the differential diagnosis for vesicular or ulcerative lesions in captive wildlife and the need for enhanced biosecurity measures at zoological parks during outbreak periods. The 2023 outbreak also demonstrated that VSNJV can be detected in a wide range of Culicoides and Simulium species, many of which had not previously been tested for the virus, suggesting that the vector community capable of supporting transmission is broader than previously appreciated [16].

In conclusion, the epidemiology of VSNJV in the Americas is characterized by a complex interplay of vector biology, host susceptibility, viral genetics, and environmental factors. Endemic transmission appears to be sustained through a cycle involving multiple insect vector species and domestic livestock, with possible contributions from sylvatic reservoirs that remain to be identified. The seasonality of clinical disease, peaking during rainy periods, reflects the increased abundance and activity of hematophagous Diptera, but subclinical infections and virus circulation during the dry season indicate that VSNJV persists even in the absence of conspicuous outbreaks. The high seroprevalence in both cattle and humans in endemic regions attests to the pervasive nature of exposure, yet the mechanisms that trigger the transition from endemic to epizootic transmission, such as the emergence of a more virulent strain, introduction of naïve livestock populations, or favorable climatic conditions, remain incompletely understood. Continued genomic surveillance, vector competence studies, and host-pathogen interaction research are essential to unravel these dynamics and to inform evidence-based control strategies.

Clinical Presentation and Pathological Lesions in Swine and Cattle

Vesicular stomatitis New Jersey virus (VSNJV) induces a disease spectrum in swine and cattle that ranges from subclinical infection to severe, debilitating vesicular disease, with the clinical trajectory profoundly influenced by viral strain, host species, inoculation route, and inoculum dose. The clinical and pathological features of VSNJV infection are of paramount importance not only for animal welfare and agricultural productivity but also because the resulting vesicular lesions are clinically indistinguishable from those caused by foot-and-mouth disease virus (FMDV), a pathogen of such catastrophic economic consequence that the World Organisation for Animal Health (WOAH) mandates immediate reporting and molecular differentiation [2]. This clinical mimicry necessitates that any vesicular condition in livestock be treated as a suspect foreign animal disease until laboratory confirmation is obtained, underscoring the critical need for a deep, mechanistic understanding of VSNJV pathogenesis in its primary livestock hosts.

Clinical Presentation in Cattle

The clinical manifestation of VSNJV in cattle is highly variable and is exquisitely sensitive to the route of virus entry. Experimental infections have demonstrated that direct inoculation of virus into the lingual epithelium, mimicking transmission via contaminated fomites or direct contact with infected saliva, consistently produces overt clinical disease. Intralingual injection of 10⁸ TCID₅₀ of VSNJV results in the development of characteristic vesicles at the inoculation site within 24 to 48 hours, progressing from erythematous macules to fluid-filled vesicles that subsequently rupture, leaving painful, erosive ulcers [4]. These primary lesions are typically confined to the dorsum of the tongue, the dental pad, and the oral mucosa, and are accompanied by profuse salivation, anorexia, and reluctance to eat or drink. The pain associated with oral lesions often manifests as repeated chewing motions, drooling, and a characteristic "smacking" of the lips.

However, the clinical picture is markedly different when VSNJV is transmitted via its natural biological vectors, the hematophagous insects that are now recognized as the primary drivers of epidemic spread. When infected Culicoides sonorensis biting midges were allowed to blood-feed on naïve steers, none of the animals developed clinical signs of vesicular stomatitis, despite all animals seroconverting and mounting a detectable antibody response [4]. This striking observation, that vector-borne transmission can result in entirely subclinical infection, has profound epidemiological implications. It suggests that during natural outbreaks, a substantial proportion of infected cattle may serve as undetected amplifying hosts, shedding virus without exhibiting the telltale lesions that would trigger diagnostic investigation. The absence of clinical signs in these animals was associated with a slower antibody response compared to intralingually inoculated animals, likely reflecting the lower dose of virus delivered by insect bite versus syringe inoculation [4].

Further complicating the clinical picture, the anatomical site of insect feeding has been shown to be a critical determinant of disease outcome. In a landmark study using Simulium vittatum black flies experimentally infected with VSNJV, clinical disease, characterized by local viral replication and vesicular lesion formation, occurred only when infected flies fed at sites where VS lesions are typically observed: the muzzle, nostrils, and coronary bands of the feet [6]. When the same infected flies were allowed to feed on the flank or neck skin, viral replication was poor, lesions were not observed, and only low levels of neutralizing antibodies (titers ranging from 1:8 to 1:32) developed [6]. This site-dependent susceptibility likely reflects differences in epithelial thickness, keratinization, and local immune surveillance. The thin, non-keratinized epithelium of the oral mucosa and coronary band provides a more permissive environment for viral entry and replication compared to the heavily keratinized skin of the trunk. Importantly, viremia was never detected in any of these animals, and infectious virus could not be recovered from tissues at necropsy performed 8 to 27 days post-infection, indicating that VSNJV infection in cattle is a highly localized, epitheliotropic process without systemic dissemination [6].

The severity of clinical disease in cattle is also modulated by viral strain. Comparative studies using homologous VSNJV strains (those isolated from the same geographic region as the challenge host) versus heterologous strains have revealed significant differences in clinical scores. Infection of cattle with a homologous virus (e.g., NJ82COB or NJ82AZB) resulted in more severe clinical presentation, characterized by larger and more numerous vesicles, more extensive epithelial erosion, and a greater extent and duration of viral shedding compared to infection with heterologous strains such as NJ06WYE or NJOSF [21]. This host predilection suggests that VSNJV strains circulating within specific geographic regions may be locally adapted to the cattle populations they encounter, potentially through co-evolutionary pressures that optimize viral replication in the host's epithelial microenvironment. The practical consequence is that viral transmission via both animal-to-animal contact and insect vectors is likely to occur at higher rates when affected animals present with severe clinical signs and shed high concentrations of virus, creating a positive feedback loop that accelerates epidemic spread [21].

Clinical Presentation in Swine

Swine represent a particularly important host for VSNJV, not only because they develop clinical disease that is economically significant but also because they may serve as amplifying hosts that sustain viral transmission during inter-epidemic periods. The clinical presentation in pigs is largely determined by the route of inoculation, with intradermal deposition of virus into the snout, the most common natural exposure site, producing the most consistent and severe disease.

Intradermal inoculation of the snout with as little as 10⁴ TCID₅₀ of VSNJV reliably produces primary vesicular lesions at the inoculation site within 24 to 48 hours [22]. These lesions begin as focal areas of erythema and swelling that rapidly progress to fluid-filled vesicles, typically 0.5 to 2.0 cm in diameter. The vesicles are fragile and rupture easily, leaving raw, hemorrhagic erosions that are exquisitely painful. Secondary lesions frequently develop at distant sites, including the coronary bands of the feet, the oral mucosa, and the tongue, reflecting the ability of the virus to spread from the primary inoculation site via lymphatic drainage and possibly through direct contact with contaminated saliva or exudate [1, 22]. The development of secondary vesicular lesions is a hallmark of severe VSNJV infection in swine and is associated with higher viral loads and more prolonged shedding.

The severity of clinical disease in swine is directly correlated with the virus's ability to counteract the host innate immune response, particularly within macrophages. A critical advance in understanding this relationship came from studies using a recombinant VSNJV mutant containing a single amino acid substitution in the matrix protein (M51R). This mutation abrogates the virus's ability to suppress the transcription of genes associated with the innate immune response in porcine macrophages, resulting in impaired viral replication specifically in these cells [1]. When pigs were inoculated with the M51R mutant via intradermal scarification of the snout, the resulting clinical disease was markedly attenuated compared to infection with the parental wild-type virus. Pigs infected with the M51R mutant developed fewer and smaller secondary vesicular lesions, exhibited reduced fever, and had decreased levels of viral shedding with a complete absence of detectable RNAemia [1]. Remarkably, despite this attenuation, the M51R mutant retained the ability to infect pigs by direct contact and to cause primary lesions at the inoculation site, indicating that the mutation resulted in a partially attenuated phenotype rather than complete avirulence [1]. This study provides compelling evidence that the M51 residue of the matrix protein is essential for efficient replication in porcine macrophages and that the ability to suppress the innate immune response in these cells is a key determinant of virulence in swine.

Transcriptomic analyses of VSNJV-infected porcine macrophages have revealed the molecular basis for this immune evasion. Infection with highly virulent epidemic strains induces the massive expression of multiple anorexic, pyrogenic, proinflammatory, and immunosuppressive genes, while simultaneously suppressing the interferon (IFN) response, leading to a complete absence of stimulation of interferon-stimulated genes (ISGs) [9]. This suppression is achieved through multiple mechanisms, including the well-characterized inhibition of host gene expression mediated by the matrix protein, as well as the upregulation of several genes known to downregulate IFNβ expression [9]. The net effect is a permissive environment for viral replication, with macrophages serving as viral factories that facilitate local amplification and subsequent dissemination to secondary sites.

Pathological Lesions: Gross and Histopathological Features

The gross pathological lesions of VSNJV infection in both swine and cattle are characterized by the formation of intraepithelial vesicles that are histologically indistinguishable from those caused by FMDV. The earliest microscopic changes occur within the stratum spinosum of the epithelium, where infected keratinocytes undergo ballooning degeneration characterized by cellular swelling, cytoplasmic vacuolization, and nuclear pyknosis. As infection progresses, intercellular edema (acantholysis) develops, leading to the separation of keratinocytes and the formation of microvesicles that coalesce into macroscopic vesicles [18]. The vesicle roof is composed of the superficial layers of the epithelium, while the floor consists of the basal cell layer and underlying dermis. Rupture of the vesicle exposes the highly vascularized dermal papillae, resulting in a painful, hemorrhagic erosion that is susceptible to secondary bacterial infection.

In cattle, the most common sites for vesicle formation are the dorsal surface of the tongue, the dental pad, the lips, and the coronary bands of the feet. Lesions on the tongue can be extensive, with vesicles reaching several centimeters in diameter, and their rupture results in large, irregular ulcers that are covered by a fibrinous exudate. Coronary band lesions are particularly debilitating, as they cause severe lameness and may lead to sloughing of the hoof horn in severe cases. Histopathological examination of affected tissue reveals extensive necrosis of the epithelium, with infiltration of neutrophils and mononuclear cells into the underlying dermis. Viral antigen can be detected within the cytoplasm of degenerating keratinocytes using immunohistochemistry or RNA in situ hybridization, as demonstrated in recent studies of VSNJV infection in rhinoceros, which showed viral RNA localized specifically within histologic lesions [18].

In swine, the distribution of lesions is similar but with a predilection for the snout, which is the primary site of virus entry in natural infections. The snout lesions are typically more severe than those observed in cattle, possibly reflecting the higher density of sensory nerve endings and the greater vascularity of the porcine nasal planum. Secondary lesions on the coronary bands and oral mucosa are common in severely affected animals, and their presence is a reliable indicator of systemic viral dissemination [1, 22]. Histologically, the lesions in swine are identical to those in cattle, with ballooning degeneration of keratinocytes, acantholysis, and vesicle formation. The absence of viremia in both species, despite the development of secondary lesions, suggests that viral dissemination occurs primarily through the lymphatic system, with virus trafficking from the primary inoculation site to regional lymph nodes and then to distant epithelial sites via efferent lymphatics [6, 22].

Viral Shedding and Transmission Dynamics

The clinical presentation of VSNJV is intimately linked to the dynamics of viral shedding, which in turn determines the potential for transmission to naïve hosts. In swine, virus can be isolated from swab specimens of the nasal planum, nasal cavity, saliva, tonsil, and feces from infected animals, with the highest titers observed when lesions are present and before seroconversion [22]. The infective doses recovered from these swabs are sufficient for both contact transmission (via direct nose-to-nose contact or contamination of shared feed and water sources) and mechanical vector transmission (via the contaminated mouthparts of biting flies that feed on vesicular lesions and then move to a naïve host) [7, 22]. The demonstration that black flies (Simulium vittatum) can mechanically transmit VSNJV to naïve swine after interrupted feeding on a vesicular lesion on a previously infected host provides a direct link between clinical disease and vector-borne transmission [7]. This mechanical transmission route is particularly important during epidemics, as it allows for rapid, short-distance spread of the virus within and between herds.

In cattle, viral shedding follows a similar pattern, with high concentrations of virus present in vesicular fluid, saliva, and nasal secretions during the acute phase of infection. The duration of shedding is influenced by viral strain, with homologous strains resulting in more prolonged shedding compared to heterologous strains [21]. The absence of clinical signs in cattle infected via vector-borne transmission, however, raises the possibility that subclinically infected animals may shed virus at lower levels or for shorter durations, potentially limiting their role in onward transmission. Nevertheless, the detection of VSNJV RNA in wild-caught Culicoides and Simulium species during outbreaks, combined with the recovery of infectious virus from these insects, confirms that vector-borne transmission is a major driver of epidemic spread [16, 17].

Zoonotic Considerations and Occupational Risk

While this section focuses on clinical presentation in livestock, it is essential to acknowledge that VSNJV is a zoonotic pathogen capable of causing disease in humans, particularly those with occupational exposure to infected animals. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recognize vesicular stomatitis as an occupational hazard for veterinarians, livestock handlers, and laboratory workers. Human infection typically presents as an acute, self-limited febrile illness with influenza-like symptoms, including headache, myalgia, and malaise, occasionally accompanied by vesicular lesions on the hands, mouth, or pharynx [12]. Serological surveys in endemic regions of Central America have demonstrated high seroprevalence rates among agricultural workers, with VSNJV seropositivity reaching 40.8% in some dairy farming communities [12]. This occupational risk underscores the importance of implementing appropriate biosafety measures when handling infected animals or diagnostic specimens and highlights the need for integrated One Health surveillance approaches that encompass both animal and human health.

Differential Diagnosis and Clinical Significance

The clinical presentation of VSNJV in swine and cattle is a diagnostic challenge of the highest order, as the vesicular lesions are clinically indistinguishable from those caused by FMDV, swine vesicular disease virus (SVDV), and, in some cases, senecavirus A. The World Organisation for Animal Health (WOAH) classifies vesicular stomatitis as a notifiable disease, and any suspicion of vesicular lesions in livestock must trigger an immediate diagnostic investigation. The development of rapid, field-deployable molecular assays, such as reverse transcription loop-mediated isothermal amplification (RT-LAMP) combined with lateral-flow devices, has greatly enhanced the ability to differentiate VSNJV from FMDV and SVDV directly from epithelial suspensions without the need for prior RNA extraction [2]. These tools are critical for timely decision-making in the field, enabling rapid implementation of control measures and preventing the unnecessary slaughter of animals that would be required if FMDV were confirmed.

In summary, the clinical presentation and pathological lesions of VSNJV in swine and cattle are characterized by a spectrum of disease severity that is modulated by viral strain, host species, inoculation route, and the integrity of the host innate immune response. The ability of the virus to cause subclinical infections when transmitted by insect vectors, combined with its capacity to induce severe vesicular disease when introduced directly into susceptible epithelium, creates a complex epidemiological landscape that challenges both diagnosis and control. The recognition that macrophages play a central role in determining the outcome of infection, and that the matrix protein is a key virulence determinant, provides a molecular framework for understanding these clinical observations and offers potential targets for the development of attenuated vaccine strains and antiviral therapies.

Differential Diagnosis and Advanced Molecular Detection Methods (RT-LAMP, RT-PCR)

The accurate and rapid differentiation of Vesicular Stomatitis New Jersey Virus (VSNJV) from other vesicular disease agents represents a cornerstone of veterinary diagnostics, biosecurity, and international trade compliance. The clinical presentation of VSNJV infection in susceptible livestock, characterized by vesicular lesions of the mouth, coronary bands, and teats, is virtually indistinguishable from that caused by Foot-and-Mouth Disease Virus (FMDV), Swine Vesicular Disease Virus (SVDV), and, to a lesser extent, Vesicular Exanthema of Swine Virus (VESV) [2]. This diagnostic conundrum is not merely an academic exercise; the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) mandate the immediate notification and laboratory confirmation of any vesicular disease suspicion, given the catastrophic economic consequences of an FMD incursion into previously free regions. The zoonotic potential of VSNJV, while typically resulting in a self-limited, influenza-like illness in humans, further complicates the differential diagnosis, particularly in occupational settings where agricultural workers present with febrile syndromes [12]. The challenge is exacerbated in endemic zones of southern Mexico, Central America, and northern South America, where VSNJV cocirculates with FMDV in some regions and where environmental conditions, including temperature, precipitation, and altitude, influence viral ecological dynamics [11, 17].

The Clinical and Epidemiological Basis for Differential Diagnosis

The differential diagnosis of VSNJV must be considered at multiple levels: clinical, epidemiological, and molecular. Clinically, the hallmark of infection is the formation of vesicles and subsequent erosions on the oral mucosa, tongue, dental pad, coronary bands, and teats [21, 22]. However, lesion distribution and severity can vary significantly depending on the host species, viral strain, and route of exposure. Experimental transmission studies in cattle have demonstrated that infection via the bite of infected Simulium vittatum black flies results in vesicular lesions only when feeding occurs at sites typical of natural disease (mouth, nostrils, coronary band), whereas feeding on the flank or neck produces subclinical infection with low-level seroconversion [6]. Similarly, transmission by Culicoides sonorensis biting midges to cattle yielded seroconversion without visible lesions, suggesting that a substantial proportion of natural infections may be subclinical, thereby complicating syndromic surveillance [4]. In swine, intradermal scarification of the snout consistently produces vesicles, while other routes such as oral inoculation or intranasal instillation may result in seroconversion without clinical signs [22]. These observations underscore that a negative clinical examination does not rule out VSNJV infection, particularly in vector-borne transmission scenarios.

Epidemiological factors provide valuable contextual clues. VSNJV outbreaks in the United States are typically sporadic and associated with northward viral emergence from endemic foci in southern Mexico [13, 17]. Phylogenetic analyses of VSNJV isolates from the 2012 U.S. epidemic and their closest relatives from Mexico have revealed a striking genetic relatedness, supporting a model of periodic introduction rather than continuous endemic circulation [13]. In contrast, FMDV exhibits a global distribution with endemicity in much of Africa, Asia, and parts of South America, and its transmission is primarily via direct contact and aerosol, with insect vectors playing no role. The demonstration that VSNJV can be mechanically transmitted by black flies after interrupted feeding on vesicular lesions [7], and that infectious virus can be detected in wild-caught Culicoides and Simulium species during active outbreaks [16], provides a powerful epidemiological discriminant. Furthermore, the host predilection of different VSNJV strains, where homologous strains cause more severe disease and prolonged shedding in their species of origin compared with heterologous strains, adds another layer of complexity to the diagnostic picture [21]. Feral swine, which have been proposed as potential amplifying hosts, rarely show serological evidence of VSNJV exposure in the western United States, further narrowing the differential [20].

Advanced Molecular Detection: Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR)

The current gold standard for confirmatory diagnosis of VSNJV is reverse transcription quantitative polymerase chain reaction (RT-qPCR), which offers unparalleled sensitivity and specificity for the detection of viral RNA in clinical specimens. RT-qPCR assays target conserved regions of the VSNJV genome, most commonly the nucleoprotein (N) gene, the phosphoprotein (P) gene, or the polymerase (L) gene, depending on the specific assay design [1, 8, 9]. The analytical sensitivity of these assays is exceptional; experimental comparisons have demonstrated that the limit of detection (LoD) for laboratory-based real-time RT-qPCR is equivalent to that achieved by the most sensitive RT-LAMP assays, typically in the range of 10–100 RNA copies per reaction [2].

The utility of RT-qPCR extends beyond mere detection. Viral RNA can be quantified to assess shedding dynamics, as demonstrated in experimental infection studies where viral RNA was detected up to 9 days postinfection in tissues from lesion sites and draining lymph nodes of cattle infected by black fly bite [6]. In pigs infected with a highly virulent VSNJV strain, RT-qPCR revealed the absence of RNAemia in animals inoculated with an attenuated M51R mutant, correlating with decreased clinical severity and reduced viral shedding [1]. Similarly, in the first reported outbreak of VSNJV in rhinoceros species at a California zoological park, RT-qPCR was instrumental in confirming infection in 10 of 26 animals, enabling the implementation of quarantine and biosecurity measures [18]. The assay's ability to detect viral RNA in swab samples from vesicular lesions, saliva, and even fecal specimens has been well documented in experimental swine infections [22].

The specificity of RT-qPCR is equally critical. Multiplex RT-qPCR panels have been developed that can simultaneously differentiate VSNJV from FMDV, SVDV, and VSIV in a single reaction, drastically reducing turnaround time compared with sequential single-target testing [2]. This multiplexing capability is indispensable in outbreak settings where the differential diagnosis is urgent. However, RT-qPCR requires sophisticated laboratory infrastructure, including thermocyclers with real-time fluorescence detection, trained personnel, and a reliable supply of reagents and consumables. The requirement for purified RNA, typically extracted using column-based or magnetic bead-based methods, adds time and cost to the diagnostic workflow. While lyophilized reagents and field-deployable thermocyclers have improved portability, the technology remains largely confined to central or regional veterinary diagnostic laboratories.

The Paradigm Shift toward RT-LAMP for Field Deployment

The limitations of RT-qPCR in resource-limited or remote settings have driven the development of reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a rapid, sensitive, and field-deployable alternative for VSNJV detection [2]. RT-LAMP employs a set of four to six primers that recognize six to eight distinct regions of the target gene, typically the N gene or the L gene, allowing amplification to occur at a constant temperature (60–65°C) without the need for thermal cycling. The reaction produces a characteristic ladder-like banding pattern on gel electrophoresis, a turbidity change due to magnesium pyrophosphate precipitation, or a fluorescent signal when intercalating dyes or probe-based detection systems are used.

The seminal work by Fowler et al. (2016) established the first RT-LAMP assay specifically for VSNJV detection, designed to complement existing assays for FMDV and SVDV [2]. The VSNJV RT-LAMP assay demonstrated a limit of detection equivalent to that of laboratory-based real-time RT-qPCR, a remarkable achievement given the inherent simplicity of the isothermal platform. Critically, the assay was validated on epithelial suspensions, the most common sample type collected from vesicular lesions, and performed reliably without the need for prior RNA extraction. This "sample-to-answer" capability eliminates a major bottleneck in molecular diagnostics, as RNA extraction is often the rate-limiting step in field laboratories. The assay was further adapted into a multiplex format combining RT-LAMP with molecular lateral-flow devices, enabling visual discrimination between FMDV, SVDV, and VSNJV on a single test strip [2]. This represents a transformative approach to differential diagnosis, allowing non-specialist personnel in endemic regions to make rapid, informed decisions regarding disease control.

The biological rationale for RT-LAMP's success in VSNJV detection lies in its tolerance of inhibitors commonly present in clinical samples, such as heme, bile salts, and tissue debris. This robustness is particularly relevant for vesicular disease diagnosis, where epithelial lesion swabs and suspensions are notoriously difficult to process using conventional PCR due to the presence of polysaccharides, proteoglycans, and other contaminants. Furthermore, the high amplification efficiency of LAMP, producing up to 10^9 copies of target DNA within 30–60 minutes, compensates for the lower starting template that may be present in early infections or subclinical cases. Studies on VSNJV transmission dynamics have shown that viral RNA can be detected by RT-qPCR in the absence of clinical lesions, as observed in cattle infected by Culicoides sonorensis bite [4, 10]. RT-LAMP, with its equivalent sensitivity, is well positioned to capture these subclinical infections, which are epidemiologically critical yet notoriously difficult to confirm using conventional methods.

The integration of RT-LAMP into a "One Health" surveillance framework is particularly compelling. Given the documented occupational risk of VSNJV exposure in agricultural workers, with seroprevalence rates as high as 40.8% in dairy regions of Costa Rica [12], a rapid, point-of-care diagnostic capable of differentiating VSNJV from other vesicular viruses would not only benefit animal health but also protect human health through early identification of zoonotic cases. The use of lateral-flow readouts eliminates the need for specialized equipment, enabling deployment in livestock markets, quarantine stations, and mobile veterinary units. The potential for linking RT-LAMP results to real-time geospatial databases, as pioneered in FMD control programs, could transform outbreak response by enabling near-real-time mapping of VSNJV distribution.

Despite its advantages, RT-LAMP is not without limitations. The complex primer design required for VSNJV, given the genetic diversity among field strains circulating in endemic regions of Mexico, Central America, and South America, demands continuous in silico validation against newly emerging sequences [3, 5, 11, 13]. Cross-reactivity with closely related vesiculoviruses, such as Vesicular Stomatitis Indiana Virus (VSIV), must be rigorously excluded through empirical testing. Additionally, the inability to perform multiplex reactions with more than four or five targets without compromising sensitivity remains a technical hurdle. The development of lyophilized RT-LAMP master mixes, which can be stored at ambient temperatures for extended periods, partially addresses the cold-chain requirements that have hindered broader adoption in tropical environments.

In summary, the differential diagnosis of VSNJV demands a multi-pronged approach integrating clinical acumen, epidemiological intelligence, and molecular precision. While RT-qPCR remains the reference standard for confirmatory testing in central laboratories, RT-LAMP has emerged as a powerful and practical alternative for field deployment, offering equivalent sensitivity, robust performance in crude samples, and the capacity for multiplex discrimination between vesicular disease agents. The ongoing validation of RT-LAMP against the genetically diverse VSNJV strains circulating in endemic regions, coupled with the refinement of sample collection and processing protocols, will be essential for realizing the full potential of this technology in the global effort to control vesicular stomatitis.

Immune Response Mechanisms and Attenuation Strategies in Natural Hosts

Innate Immune Evasion by VSNJV: The Role of the Matrix Protein

A cornerstone of Vesicular Stomatitis New Jersey Virus (VSNJV) pathogenesis in its natural hosts, swine, cattle, and horses, is its capacity to subvert the host innate immune response, particularly the type I interferon (IFN) system. The viral matrix (M) protein is the primary effector of this immunosuppression. Seminal work using a reverse genetics platform [8] to engineer a single amino acid substitution (M51R) in the epidemic strain NJ0612NME6 demonstrated that this residue is essential for blocking IFN-β transcription in porcine cells. The M51R mutant lost the ability to suppress innate immune gene expression in both primary fetal porcine kidney cells and, critically, in porcine primary macrophage cultures [1]. In macrophages, this loss of suppression correlated with impaired viral replication, indicating that the M protein’s anti-IFN function is a prerequisite for efficient growth in these key immune cells [1]. Consequently, in vivo infection of pigs via intradermal scarification with the M51R mutant resulted in a significantly attenuated phenotype: reduced fever, fewer and smaller secondary vesicular lesions, decreased viral shedding, and absence of RNAemia, although the ability to transmit via direct contact remained intact [1]. This provides a direct causal link between the virus’s capacity to counteract the innate response in macrophages and its virulence in a natural host.

Beyond the well-characterized M protein-mediated blockade of host transcription [1, 14], transcriptomic analyses of VSNJV-infected porcine macrophages have revealed a more nuanced and multifactorial suppression strategy. Microarray profiling showed that infection with a highly virulent epidemic strain induced massive expression of anorexic, pyrogenic, proinflammatory, and immunosuppressive genes, yet the interferon response itself was conspicuously suppressed, leading to a lack of stimulation of interferon-stimulated genes (ISGs) [9]. Importantly, the virus promoted the expression of several genes known to downregulate IFN-β, suggesting that VSNJV employs both direct (via M protein) and indirect mechanisms to disable the IFN axis [9]. Interestingly, a less virulent endemic strain consistently induced higher expression of all upregulated cytokines and chemokines compared to the epidemic strain, implying that the intensity of the host inflammatory response, rather than its complete absence, may correlate with virulence levels [9]. This finding underscores that VSNJV pathogenesis involves a delicate balance between immune activation and evasion, with the most virulent strains achieving a more profound suppression of the antiviral state.

Macrophage Tropism and Transcriptional Reprogramming

Macrophages serve as a central battleground for VSNJV infection in livestock. The virus demonstrates a clear tropism for these cells, and the efficiency of replication within porcine macrophages is a direct determinant of systemic spread and clinical outcome [1, 9]. The M51R mutation, which cripples innate immune suppression, abrogates viral growth specifically in macrophage cultures but not in other cell types, highlighting the macrophage’s role as a sentinel whose subversion is critical for pathogenesis [1]. Transcriptional reprogramming of infected macrophages involves the upregulation of numerous pro-inflammatory mediators (e.g., IL-1β, TNF-α, and chemokines) alongside immunosuppressive factors, creating a complex environment that facilitates viral dissemination while dampening the antiviral response [9]. This dual effect may explain the intense local inflammation seen at vesicular lesions while systemic viremia remains undetectable in natural hosts [6, 22]. The absence of viremia in cattle and pigs, even during severe clinical disease [6, 22], suggests that virus spreads locally via lymphatics and nerves, with macrophages acting both as viral factories and as vehicles for regional dissemination. Indeed, viral RNA has been detected in lymph nodes draining lesion sites up to 9 days post-infection in cattle [6], reinforcing the importance of these cells in sustaining infection.

Attenuation Strategies: Genetic Determinants and Reverse Genetics

The identification of the M protein as a key virulence factor has driven the rational design of attenuated VSNJV strains for vaccine development. Beyond the M51R mutation, combinatorial mutations in the M gene have been explored. For the New Jersey serotype, engineered mutations G22E, M48R, and M51R (termed GMM) and the quadruple G22E, M48R, M51R, and L110F (GMML) have been evaluated [14]. These M gene mutants exhibit drastically reduced cytopathic effects in vitro and profound attenuation in animal models: whereas as few as 1,000 plaque-forming units of wild-type VSV are lethal to mice within four days, animals inoculated with up to 5 × 10⁹ live M gene mutant virions showed no adverse effects [14]. This remarkable safety profile, coupled with the ability of these vectors to induce robust humoral and cellular immune responses against inserted heterologous glycoproteins, has positioned recombinant VSNJV (rVSVNJ) as a leading platform for vaccine development, including responses against emerging RNA viruses [14] and porcine circoviruses via virus-like vesicles (rVLVs) incorporating VSNJV glycoprotein [19].

The reverse genetics system for VSNJV, validated through the recovery of infectious recombinant virus from a full-length cDNA clone of the virulent NJ0612NME6 strain [8], enables precise manipulation of the genome. This system allowed the construction of the M51R mutant used in pathogenesis studies [1] and facilitates the rapid generation of rationally attenuated strains. The use of site-specific recombination cloning accelerates the process, making it feasible to produce recombinant field isolates for functional studies [8]. Such tools are essential for dissecting the molecular basis of virulence and for developing live-attenuated vaccines that retain immunogenicity while eliminating disease potential.

Natural Attenuation via Vector Transmission and Host Species Predilection

An intriguing aspect of VSNJV ecology is that natural transmission by insect vectors can result in attenuated clinical outcomes compared to direct inoculation. When cattle were infected via the bite of infected Culicoides sonorensis midges, none developed clinical vesicles, despite seroconversion [4]. In contrast, intralingual inoculation with a high dose of virus consistently produced lesions [4]. Similarly, guinea pigs infected by C. sonorensis bite seroconverted without signs, whereas footpad inoculation caused vesicular disease [10]. This attenuation is likely due to the lower dose of virus delivered by insect feeding compared to syringe injection, but also possibly to the immunomodulatory effects of insect saliva [4]. Interestingly, when black flies (Simulium vittatum) fed on cattle at anatomical sites where natural lesions occur (mouth, nostrils, coronary band), clinical vesicles developed, whereas feeding on flank or neck skin resulted only in low-level antibody responses and no lesions [6]. Thus, site of feeding, and by extension, the local tissue environment, profoundly influences disease expression. This may explain widespread subclinical infections during epidemics [4].

Host species also display differential susceptibility. In controlled trials, homologous VSNJV strains (e.g., NJ82COB) caused more severe clinical signs and longer viral shedding in cattle compared to heterologous strains, while swine showed less variation between strains [21]. The more severe clinical presentation in a homologous host is expected to drive faster and farther viral spread during outbreaks due to higher titers shed from lesions [21]. Swine have been proposed as an effective large-animal model for studying VSNJV transmission, as they shed sufficient virus from snout and oral swabs for contact and mechanical vector transmission [22]. In pigs, infection via intradermal snout inoculation reliably produces vesicles, and viral titers are highest before seroconversion, emphasizing the importance of the presymptomatic period for transmission [22]. Mechanical transmission by black flies has been demonstrated: after interrupted feeding on a vesicular lesion, flies can transmit VSNJV to a naïve pig, resulting in clinical disease [7]. This mechanism likely contributes to explosive epizootics seen in the western United States [7, 16].

Vaccine Development and Attenuated Vector Platforms

The attenuation strategies derived from M gene mutations have been translated into practical vaccine candidates. The rVSVNJ-GMM and rVSVNJ-GMML vectors serve as backbones for expressing foreign glycoproteins, stimulating both neutralizing antibody and T-cell responses [14]. These vectors are designed to prevent vector immunity during booster immunizations by using different serotypes (Indiana vs. New Jersey) [14]. Additionally, virus-like vesicles (rVLVs) composed of the VSNJV glycoprotein incorporated into Venezuelan equine encephalitis virus replicon particles have been shown to induce IFN-γ and IL-4 responses in mice, demonstrating their potential for swine vaccines [19]. The oncolytic potential of VSNJV has also been explored, with the New Jersey serotype showing high lytic activity against melanoma and hepatocellular carcinoma cell lines [23], suggesting that attenuated mutants could be repurposed for virotherapy.

Surveillance studies in endemic regions of southern Mexico and Central America reveal that VSNJV is maintained in a sylvatic cycle involving multiple insect vector taxa (black flies, biting midges, sandflies, mosquitoes), with viral RNA detected in all groups during both rainy and dry seasons [17]. This year-round transmission in the absence of clinical livestock cases implies that alternative reservoir hosts or vertical transmission in insects sustain the virus [17]. Feral swine in the western US do not appear to serve as an endemic reservoir, with only a single seropositive animal detected among over 4,500 samples [20], reinforcing the hypothesis that epidemics originate from reintroductions from southern endemic foci.

Human seroprevalence studies in Costa Rica demonstrate that VSNJV is the predominant serotype in agricultural workers, with seropositivity reaching 40.8% in one dairy canton, and a significant association with cattle contact [12]. This zoonotic potential underscores the need for a One Health approach and for safe, effective vaccines that can prevent both livestock disease and human exposure. The attenuated M gene mutants of VSNJV offer a path forward, combining safety with immunogenicity.

Viral Replication, Host Range, and Cell Tropism Determinants

The molecular architecture governing Vesicular Stomatitis New Jersey Virus (VSNJV) replication, host range restriction, and cell tropism represents a sophisticated interplay between viral genetic determinants and host cellular factors. As a member of the Rhabdoviridae family, genus Vesiculovirus, VSNJV exhibits a broad host range that encompasses domestic livestock, wildlife species, and humans, yet the efficiency of viral replication varies dramatically across different cell types, tissues, and host species [1, 14, 21]. Understanding these determinants is essential for elucidating the mechanisms underlying viral pathogenesis, transmission dynamics, and the sporadic emergence of epizootic strains from endemic foci in southern Mexico and Central America [3, 5, 13, 17].

The Replicative Cycle in Permissive Cells

VSNJV replication begins with viral attachment to host cell receptors, primarily mediated by the viral glycoprotein (G) interacting with the low-density lipoprotein receptor (LDLR) family, which is ubiquitously expressed on mammalian cells [14]. This receptor utilization explains the remarkably broad cell tropism observed in vitro, where VSNJV can infect and replicate in virtually all mammalian cell lines tested, including BHK-derived cells (BSR-T7/5), Vero-E6 cells, primary porcine kidney cells, and numerous cancer cell lines [8, 12, 23]. Following receptor-mediated endocytosis and low-pH-dependent membrane fusion within endosomal compartments, the viral ribonucleocapsid is released into the cytoplasm, where transcription and replication occur exclusively in the cytoplasmic compartment [8, 14].

The viral RNA-dependent RNA polymerase, composed of the large protein (L) and the phosphoprotein (P), initiates primary transcription from the negative-sense genomic RNA, producing five monocistronic mRNAs encoding the nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and the polymerase (L) in a sequential gradient from the 3′ to 5′ end of the genome [8, 13]. The replication kinetics of VSNJV are remarkably rapid, with progeny virions detectable within 4–6 hours post-infection in permissive cell lines, and peak titers reaching 10⁸–10⁹ TCID₅₀/mL under optimal conditions [8, 23]. This explosive replication capacity is a hallmark of the virus and contributes directly to its cytopathic effect and virulence in susceptible hosts [1, 21].

The Matrix Protein: A Pivotal Determinant of Replication Efficiency and Host Restriction

Perhaps the most critical determinant of VSNJV replication efficiency in specific host cells is the matrix protein, particularly residue 51 (M51), which has been identified as a master regulator of both viral replication and innate immune evasion [1, 14]. The highly virulent epidemic strain NJ0612NME6 possesses a methionine at position 51 of the M protein, and this residue is required for efficient replication in porcine macrophages [1]. Velázquez-Salinas and colleagues demonstrated that a single amino acid substitution (M51R) in the matrix protein dramatically impaired viral growth specifically in cultured porcine macrophages, whereas replication in primary fetal porcine kidney cells remained largely unaffected [1]. This cell-type-specific restriction indicates that macrophages impose unique selective pressures on VSNJV replication that are not present in epithelial or fibroblast cell populations.

The M51 residue functions primarily through its role in suppressing the host innate immune response. The wild-type M protein inhibits host gene transcription, including the expression of interferon-beta (IFN-β) and interferon-stimulated genes (ISGs), thereby creating a permissive intracellular environment for viral replication [1, 9]. The M51R mutant, by contrast, is unable to suppress the transcription of innate immune genes in both porcine macrophages and primary kidney cells, yet replication is only impaired in macrophages [1]. This observation suggests that macrophages possess a more robust or rapidly deployed antiviral response that can effectively restrict viral replication when the M protein is compromised, whereas kidney cells may rely on alternative or less stringent antiviral mechanisms.

Transcriptomic analyses of VSNJV-infected porcine macrophages have revealed a complex interplay between viral manipulation and host defense [9]. Infection with wild-type virus induces massive expression of multiple anorexic, pyrogenic, proinflammatory, and immunosuppressive genes, while the interferon response appears paradoxically suppressed, leading to the absence of ISG stimulation [9]. Remarkably, VSNJV infection promotes the expression of several genes known to downregulate IFN-β expression, revealing an alternate mechanism for controlling the interferon response that extends beyond the direct transcriptional inhibition mediated by the matrix protein [9]. These findings highlight the multi-layered strategy employed by VSNJV to establish productive infection in macrophages, which are otherwise potent antiviral effector cells.

Host Range Determinants: Species-Specific Restrictions and Permissiveness

The host range of VSNJV encompasses an exceptionally broad array of mammalian species, including cattle, swine, horses, rhinoceroses, guinea pigs, and humans [1, 4, 6, 10, 12, 18, 21]. However, significant variation exists in the clinical outcome and replication efficiency across different host species, suggesting species-specific determinants that modulate viral tropism [20, 21]. Experimental infections in cattle and swine have revealed that homologous VSNJV strains (those isolated from the same geographic region as the challenge host) produce more severe clinical disease, higher viral shedding titers, and prolonged shedding duration compared with heterologous strains [21]. These findings indicate that VSNJV strains may have evolved host predilections that optimize replication in specific livestock species, potentially driven by ecological selection pressures in endemic regions.

The ability of VSNJV to infect and replicate in swine is particularly well characterized due to the importance of pigs as both a natural host and an experimental model [1, 7, 21, 22]. Pigs can be infected through multiple routes, including intradermal inoculation of the snout, scarification of the lip, oral administration, and mechanical or biological transmission by insect vectors [7, 15, 22]. Infection via intradermal snout inoculation with as little as 10⁴ TCID₅₀ results in consistent clinical disease characterized by vesicular lesions at the site of inoculation, viral shedding from the nasal planum, nasal cavity, saliva, tonsil, and feces, and subsequent seroconversion [22]. Notably, viremia is never observed in infected swine, indicating that VSNJV replication remains locally restricted to the site of inoculation and draining lymph nodes rather than disseminating systemically [6, 22].

Cattle represent another highly susceptible host species, yet the clinical outcome following VSNJV infection is profoundly influenced by the route of exposure and the anatomical site of viral deposition [4, 6]. Experimental transmission by infected Culicoides sonorensis biting midges to cattle resulted in seroconversion without clinical signs, whereas intralingual inoculation with high doses of virus produced characteristic vesicular lesions at the injection site [4]. Critically, when infected Simulium vittatum black flies fed at sites where VS lesions are usually observed (mouth, nostrils, and foot coronary band), infection resulted in local viral replication, vesicular lesions, and high neutralizing antibody titers (>1:256) [6]. However, when flies fed on flank or neck skin, viral replication was poor, lesions were not observed, and only low levels of neutralizing antibodies developed [6]. This anatomical restriction reveals that VSNJV replication is highly dependent on the tissue microenvironment, with mucosal and coronary band epithelia providing particularly permissive conditions for viral amplification.

Cell Tropism Determinants: Macrophages as Primary Targets and Antiviral Sentinels

The cell tropism of VSNJV within infected hosts is not uniform, and a growing body of evidence indicates that macrophages play a central role in determining the outcome of infection [1, 9]. Macrophages are among the first immune cells encountered by VSNJV at sites of virus introduction, whether through insect bite, direct contact, or fomite exposure [1, 9]. In swine, porcine macrophages support robust viral replication when infected with wild-type VSNJV strains, and this replication is associated with the massive transcriptional reprogramming of the host cell [9]. However, the M51R mutant virus is severely restricted in macrophage cultures, demonstrating that macrophages impose a stringent requirement for functional M protein-mediated innate immune suppression [1].

The transcriptomic signature of VSNJV-infected porcine macrophages reveals a paradoxical state: massive upregulation of proinflammatory cytokines and chemokines occurs simultaneously with suppression of the interferon response [9]. The virus promotes expression of genes that downregulate IFN-β, effectively neutralizing the primary antiviral signaling pathway of the host. Interestingly, comparative analysis of macrophages infected with a highly virulent epidemic strain versus a less virulent endemic strain revealed no significant differential gene expression, though the endemic strain consistently induced higher expression of all upregulated cytokines and chemokines [9]. This unexpected finding suggests that virulence may correlate not with the magnitude of the innate immune response, but rather with the efficiency with which the virus subverts specific antiviral pathways.

The importance of macrophages in controlling VSNJV systemic dissemination has been demonstrated across multiple animal models, including mice, cattle, and pigs [9]. The inability of the M51R mutant to replicate efficiently in porcine macrophages correlates directly with its attenuated phenotype in pigs, where infection results in decreased clinical signs, reduced fever, fewer and smaller secondary vesicular lesions, decreased viral shedding, and absence of RNAemia [1]. Despite this attenuation, the M51R mutant retains the ability to infect pigs by direct contact and cause primary lesions, indicating that the M51 residue is dispensable for initial infection but essential for efficient replication within the macrophage-rich environment of secondary lymphoid tissues [1].

Insect Vector Interactions: Replication in Arthropod Hosts

The host range of VSNJV extends beyond mammalian species to include multiple hematophagous arthropod vectors, in which the virus must replicate to achieve biological transmission [4, 6, 10, 15-17]. Unlike mechanical transmission, which involves passive transfer of virus on contaminated mouthparts, biological transmission requires viral replication within the insect host following ingestion of an infectious blood meal [7, 15]. Field surveillance studies have detected VSNJV RNA and infectious virus in multiple insect species, including Culicoides biting midges (C. sonorensis, C. bergi, C. freeborni, C. occidentalis) and Simulium black flies (S. vittatum, S. argus, S. hippovorum, S. tescorum) [4, 6, 16, 17].

Laboratory studies have confirmed that Culicoides sonorensis can support VSNJV replication following intrathoracic inoculation, with viral persistence for at least 10 days at 25°C, and can subsequently transmit infectious virus to susceptible livestock during blood feeding [4, 10]. Similarly, Simulium vittatum supports biological transmission to swine, resulting in clinical vesicular stomatitis, representing the first definitive demonstration of insect-borne clinical disease in a livestock host [15]. The ability of VSNJV to replicate at the lower temperatures characteristic of arthropod hosts (typically 25–28°C) distinguishes it from many mammalian-restricted viruses and reflects its adaptation to a vector-borne transmission cycle [4, 10].

Importantly, recent longitudinal surveillance in the endemic region of Chiapas, Mexico, has detected VSNJV RNA in all four major vector taxa (black flies, sand flies, biting midges, and mosquitoes) throughout the year, including during the dry season when no livestock cases were reported [17]. This finding strongly suggests that mechanisms other than transmission from livestock maintain VSNJV endemicity, potentially involving persistent infection in insect vectors or alternative vertebrate reservoir hosts [17]. The detection of VSIV RNA only in mosquitoes, while VSNJV was detected across all vector taxa, may reflect serotype-specific differences in vector tropism that contribute to the epidemiological dominance of VSNJV in the endemic zone [17].

Strain-Specific Tropism and Virulence Determinants

Phylogenetic analyses of VSNJV field isolates have revealed that genetic variation correlates more strongly with ecological factors than with temporal or geographic parameters [11, 13]. Molecular analysis of viruses isolated in Venezuela from 2009 to 2017 demonstrated that viruses from different ecological regions did not present significant genetic differences in the hypervariable region of the phosphoprotein gene, despite being found across a wide range of environmental conditions including variable altitudes, precipitation levels, and temperatures [11]. This genetic stability contrasts with the phenotypic variation observed in experimental infections, where different VSNJV strains exhibit marked differences in virulence, clinical presentation, and transmission efficiency in livestock [21].

Comparative genomic analysis of epidemic U.S. strains and their closest endemic relatives from southern Mexico provides an ideal model for identifying genetic factors linked with emergence and enhanced virulence [13]. The 2012 U.S. epidemic strain and its endemic counterpart from Mexico are closely related phylogenetically, suggesting that relatively few genetic changes may be responsible for the transition from endemic circulation to epizootic emergence [13]. The identification of these genetic determinants remains an active area of investigation, with the M protein, G protein, and P protein all representing potential contributors to strain-specific virulence [1, 8, 13, 14].

Recent efforts to develop attenuated VSNJV vaccine vectors have systematically identified multiple residues in the M protein that contribute to virulence and replication capacity [14]. For the New Jersey serotype, mutations at positions G22E, M48R, M51R, and L110F (designated GMML) were combined to generate highly attenuated vectors with reduced cytopathic effects in vitro and across multiple animal species. Animals injected with up to 5 billion live M gene mutant VSV showed no significant adverse effects, whereas only 1,000 wild-type VSV were sufficient to kill mice within four days [14]. The dramatic attenuation achieved through these targeted mutations underscores the central role of the M protein in determining the replication capacity and pathogenic potential of VSNJV.

Implications for Viral Ecology and Disease Emergence

The determinants of VSNJV replication, host range, and cell tropism have profound implications for understanding the ecology of this virus and predicting the emergence of epizootic strains. The demonstration that wild-type VSNJV replicates efficiently in porcine macrophages, while M51R mutants are severely restricted, establishes a direct correlation between the ability to counteract the innate immune response in macrophages and virulence in a natural host [1]. This paradigm suggests that the selective pressures encountered during transmission between mammalian hosts, or between vectors and mammals, may favor the maintenance of M protein function as a critical virulence determinant.

The broad host range of VSNJV, encompassing domestic livestock, feral swine, rhinoceroses, and humans, raises important questions about potential reservoir hosts and the mechanisms of viral maintenance during inter-epizootic periods [1, 9, 12, 18, 20]. Serosurveillance of feral swine in the western United States has revealed a very low prevalence of antibodies against VSNJV, indicating that feral swine do not represent an endemic reservoir in this region [20]. However, high seroprevalence rates (75–100% among adult cattle) in endemic regions of Chiapas, Mexico, indicate that livestock populations serve as amplifying hosts that sustain viral circulation [17]. The detection of VSNJV RNA in insects during the dry season, when livestock cases are absent, suggests that alternative mechanisms, potentially involving vertical transmission in vectors or wild vertebrate reservoirs, contribute to viral persistence [17].

The ability of VSNJV to replicate in diverse cell types across multiple host species, combined with its insect transmission capability and sophisticated immune evasion strategies, makes it a remarkably successful pathogen that continues to cause significant economic losses and animal health concerns throughout the Americas [1, 8, 13, 14, 17, 18, 21]. Understanding the molecular determinants of these biological properties is essential for developing effective control strategies, including vaccines, vector control interventions, and surveillance programs that can detect emerging strains before they initiate widespread epizootics.

References

[1] Velázquez-Salinas L, Pauszek S, Holinka L, Gladue D, Rekant S, Bishop EA, et al.. A Single Amino Acid Substitution in the Matrix Protein (M51R) of Vesicular Stomatitis New Jersey Virus Impairs Replication in Cultured Porcine Macrophages and Results in Significant Attenuation in Pigs. Frontiers in Microbiology. 2020. DOI: https://doi.org/10.3389/fmicb.2020.01123

[2] Fowler V, Howson E, Madi M, Mioulet V, Caiusi C, Pauszek S, et al.. Development of a reverse transcription loop-mediated isothermal amplification assay for the detection of vesicular stomatitis New Jersey virus: Use of rapid molecular assays to differentiate between vesicular disease viruses.. Journal of Virological Methods. 2016. DOI: https://doi.org/10.1016/j.jviromet.2016.04.012

[3] Valdez F, Velázquez-Salinas L, Zhou LH, Smoliga G, Fish I, Navarro‐López R, et al.. Near full-length genome sequence of a vesicular stomatitis New Jersey virus isolate collected from a naturally infected cow in the endemic state of Chiapas, Mexico. Microbiology Resource Announcements. 2024. DOI: https://doi.org/10.1128/mra.01007-24

[4] León AAPd, Tabachnick W. Transmission of Vesicular Stomatitis New Jersey Virus to Cattle by the Biting Midge Culicoides sonorensis (Diptera: Ceratopogonidae). Journal of medical entomology. 2006. DOI: https://doi.org/10.1603/0022-2585(2006)043[0323:TOVSNJ]2.0.CO;2

[5] Valdez F, Velázquez-Salinas L, Fish I, Smoliga G, Gajewski KP, Davis C, et al.. Genome sequence of a historical vesicular stomatitis New Jersey virus isolate collected in 1965 from a naturally infected cow in El Salvador. Microbiology Resource Announcements. 2026. DOI: https://doi.org/10.1128/mra.00041-26

[6] Mead D, Lovett K, Murphy M, Pauszek S, Smoliga G, Gray E, et al.. Experimental Transmission of Vesicular Stomatitis New Jersey Virus from Simulium vittatum to Cattle: Clinical Outcome is Influenced by Site of Insect Feeding. Journal of medical entomology. 2009. DOI: https://doi.org/10.1603/033.046.0419

[7] Smith PF, Howerth E, Carter D, Gray E, Noblet R, Mead D. Mechanical Transmission of Vesicular Stomatitis New Jersey Virus by Simulium vittatum (Diptera: Simuliidae) to Domestic Swine (Sus scrofa). Journal of medical entomology. 2009. DOI: https://doi.org/10.1603/033.046.0643

[8] Velázquez-Salinas L, Pauszek S, Barrera J, Clark BA, Borca M, Verdugo-Rodríguez A, et al.. Validation of a site-specific recombination cloning technique for the rapid development of a full-length cDNA clone of a virulent field strain of vesicular stomatitis New Jersey virus.. Journal of Virological Methods. 2019. DOI: https://doi.org/10.1016/j.jviromet.2019.01.003

[9] Velázquez-Salinas L, Canter J, Zhu JJ, Rodriguez LL. Molecular Pathogenesis and Immune Evasion of Vesicular Stomatitis New Jersey Virus Inferred from Genes Expression Changes in Infected Porcine Macrophages. Pathogens. 2021. DOI: https://doi.org/10.3390/pathogens10091134

[10] Léon APD, O'Toole D, Tabachnick W. Infection of guinea pigs with vesicular stomatitis New Jersey virus Transmitted by Culicoides sonorensis (Diptera: Ceratopogonidae).. . 2006. DOI: https://doi.org/10.1093/jmedent/43.3.568

[11] Rivera AA, Guerra WJA, Buzanovsky LP, Lima DM, Sánchez-Vázquez MJ, Júnior AAF, et al.. Molecular analysis and environmental description of vesicular stomatitis New Jersey viruses isolated in Venezuela from 2009 to 2017. Arquivos do Instituto Biológico. 2024. DOI: https://doi.org/10.1590/1808-1657000132023

[12] Ayub I, Herrero M, Dolz G. Historical Serological Evidence of Human Exposure to Vesicular Stomatitis Virus (New Jersey and Indiana Serotypes) in Dairy Regions of Costa Rica (1999). Vector Borne and Zoonotic Diseases. 2026. DOI: https://doi.org/10.1177/15303667261421864

[13] Velázquez-Salinas L, Pauszek S, Verdugo-Rodríguez A, Rodriguez LL. Complete Genome Sequences of Two Vesicular Stomatitis New Jersey Viruses Representing the 2012 U.S. Epidemic Strain and Its Closest Relative Endemic Strain from Southern Mexico. Genome Announcements. 2018. DOI: https://doi.org/10.1128/genomeA.00049-18

[14] m GK, Wu K, Kang C. Preparedness for Future Pandemics Using a Highly Effective Recombinant Vesicular Stomatitis Virus-Based Vaccine Platform Technology: Strategies for Developing Superior Vaccines. Medical Research Archives. 2025. DOI: https://doi.org/10.18103/mra.v13i12.7143

[15] Mead D, Gray E, Noblet R, Murphy M, Howerth E, Stallknecht D. Biological Transmission of Vesicular Stomatitis Virus (New Jersey Serotype) by Simulium vittatum (Diptera: Simuliidae) to Domestic Swine (Sus scrofa). Journal of medical entomology. 2004. DOI: https://doi.org/10.1603/0022-2585-41.1.78

[16] Scroggs SLP, Swanson DA, Steele TD, Hudson AR, Reister-Hendricks LM, Gutierrez J, et al.. Vesicular Stomatitis Virus Detected in Biting Midges and Black Flies during the 2023 Outbreak in Southern California. Viruses. 2024. DOI: https://doi.org/10.3390/v16091428

[17] Zhou LH, Valdez F, González IL, Urbina WF, Ocaña A, Tapia C, et al.. Vesicular Stomatitis Virus Transmission Dynamics Within Its Endemic Range in Chiapas, Mexico. Viruses. 2024. DOI: https://doi.org/10.3390/v16111742

[18] Berlin ER, Kinney ME, Howard LL, Perrin KL, Rodriguez P, Kubiski SV, et al.. Vesicular stomatitis virus in two species of rhinoceros at a California zoological park.. American Journal of Veterinary Research. 2024. DOI: https://doi.org/10.2460/ajvr.23.12.0284

[19] Wang Y, Su M, Huang Y, Ren J, Niu S, Zhao Y, et al.. Development of a novel PCV2 and PCV3 vaccine using virus-like vesicles incorporating Venezuelan equine encephalomyelitis virus-containing vesicular stomatitis virus glycoprotein. Frontiers in Veterinary Science. 2024. DOI: https://doi.org/10.3389/fvets.2024.1359421

[20] Haynes E, Cleveland CA, Brown V, Pelzel-McCluskey A, Tell RM, Stallknecht D. Surveillance of Feral Swine (Sus scrofa) in the Western USA for Antibodies to Vesicular Stomatitis Virus, 2013–21. Journal of Wildlife Diseases. 2024. DOI: https://doi.org/10.7589/JWD-D-24-00049

[21] Smith PF, Howerth E, Carter D, Gray E, Noblet R, Berghaus R, et al.. Host predilection and transmissibility of vesicular stomatitis New Jersey virus strains in domestic cattle (Bos taurus) and swine (Sus scrofa). BMC Veterinary Research. 2012. DOI: https://doi.org/10.1186/1746-6148-8-183

[22] Stallknecht D, Howerth E, Cl R, Seal B. Potential for contact and mechanical vector transmission of vesicular stomatitis virus New Jersey in pigs.. American Journal of Veterinary Research. 1999. DOI: https://doi.org/10.2460/ajvr.1999.60.01.43

[23] Isaeva A, Porozova N, Idota E, Volodina S, Lukashev A, Malogolovkin A. Comparative analysis of oncolytic potential of vesicular stomatitis virus serotypes Indiana and New Jersey in cancer cell lines. Sechenov Medical Journal. 2023. DOI: https://doi.org/10.47093/2218-7332.2023.946.14